There may be some reluctance to get involved with this stock as Risco's offer lacks credibility and it appears games are a foot. Without clarity even good news can't be rewarded.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025